{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:17:35Z","timestamp":1758403055086},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.drugalcdep.2003.11.006","type":"journal-article","created":{"date-parts":[[2004,1,17]],"date-time":"2004-01-17T10:15:06Z","timestamp":1074334506000},"page":"15-19","source":"Crossref","is-referenced-by-count":5,"title":["The utility of indirect predictors of hepatitis C viremia"],"prefix":"10.1016","volume":"74","author":[{"given":"Diana L.","family":"Sylvestre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry J.","family":"Clements","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2003.11.006_BIB1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0168-8278(99)80381-X","article-title":"Hepatitis C virus infection in the United States","volume":"31","author":"Alter","year":"1999","journal-title":"J. Hepatol."},{"key":"10.1016\/j.drugalcdep.2003.11.006_BIB2","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJM199212313272702","article-title":"The natural history of community-acquired hepatitis C in the United States. The sentinel counties chronic non-A, non-B hepatitis study team","volume":"327","author":"Alter","year":"1992","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2003.11.006_BIB3","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1097\/00042560-199802001-00003","article-title":"The importance of preventing hepatitis C virus infection among injection drug users in the United States","volume":"18","author":"Alter","year":"1998","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol."},{"key":"10.1016\/j.drugalcdep.2003.11.006_BIB4","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1053\/jhep.2001.25882","article-title":"Treatment of hepatitis C infection in injection drug users","volume":"34","author":"Backmund","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.drugalcdep.2003.11.006_BIB5","unstructured":"CDC, 1998. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention. MMWR Recomm. Rep. 47, 1\u201339."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2003.11.006_BIB6","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/00042560-199802001-00004","article-title":"Prevalence and incidence of hepatitis C virus infection among young adult injection drug users","volume":"18","author":"Garfein","year":"1998","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol."},{"key":"10.1016\/j.drugalcdep.2003.11.006_BIB7","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2105\/AJPH.86.5.655","article-title":"Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses","volume":"86","author":"Garfein","year":"1996","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2003.11.006_BIB8","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1053\/gast.2000.19582","article-title":"Hepatitis C in African-Americans: summary of a workshop","volume":"119","author":"Howell","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.drugalcdep.2003.11.006_BIB9","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/hep.510290219","article-title":"A prospective, community-based evaluation of liver enzymes in individuals with hepatitis C after drug use","volume":"29","author":"Inglesby","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.drugalcdep.2003.11.006_BIB10","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/hep.510310236","article-title":"Which patients with hepatitis C develop liver complications?","volume":"31","author":"Khan","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.drugalcdep.2003.11.006_BIB11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","article-title":"Hepatitis C virus infection","volume":"345","author":"Lauer","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2003.11.006_BIB12","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2003.11.006_BIB13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1300\/J069v20n01_03","article-title":"Hepatitis C in methadone maintenance patients: prevalence and public policy implications","volume":"20","author":"McCarthy","year":"2001","journal-title":"J. Addict Dis."},{"key":"10.1016\/j.drugalcdep.2003.11.006_BIB14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1365-2893.1999.00158.x","article-title":"The influence of host factors on the natural history of chronic hepatitis C viral infections","volume":"6","author":"Minuk","year":"1999","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.drugalcdep.2003.11.006_BIB15","doi-asserted-by":"crossref","unstructured":"National Institutes of Health, 2002. National Institutes of Health Consensus Development Conference Statement: management of hepatitis C: 10\u201312 June 2002. Hepatology 36, S3\u2013S20.","DOI":"10.1002\/hep.1840360703"},{"key":"10.1016\/j.drugalcdep.2003.11.006_BIB16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1046\/j.1525-1497.2002.10415.x","article-title":"Risk factors for hepatitis C virus infection among homeless adults","volume":"17","author":"Nyamathi","year":"2002","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2003.11.006_BIB17","doi-asserted-by":"crossref","first-page":"670","DOI":"10.2105\/AJPH.92.4.670","article-title":"Hepatitis C virus infection in young, low-income women: the role of sexually transmitted infection as a potential cofactor for HCV infection","volume":"92","author":"Page-Shafer","year":"2002","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2003.11.006_BIB18","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0168-8278(00)00097-0","article-title":"Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C","volume":"34","author":"Poynard","year":"2001","journal-title":"J. Hepatol."},{"key":"10.1016\/j.drugalcdep.2003.11.006_BIB19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0376-8716(02)00010-8","article-title":"Treating hepatitis C in methadone maintenance patients: an interim analysis","volume":"67","author":"Sylvestre","year":"2002","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2003.11.006_BIB20","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/hep.510230607","article-title":"The long-term pathological evolution of chronic hepatitis C","volume":"23","author":"Yano","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.drugalcdep.2003.11.006_BIB21","first-page":"30","article-title":"Seroepidemiology of viral infections among intravenous drug users in northern California","volume":"156","author":"Zeldis","year":"1992","journal-title":"West J. Med."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871603003168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871603003168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T14:54:56Z","timestamp":1550242496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871603003168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0376871603003168"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2003.11.006","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}